Role of osteogenic growth peptide (OGP) and OGP(10–14) in bone regeneration: A review

International Journal of Molecular Sciences

Volumn 17, Issue 11, 2016, Pages

  Pigossi, Suzane C ^a   Medeiros, Marcell C ^a   Saska, Sybele ^a   Cirelli, Joni A ^a   Scarel Caminaga, Raquel M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Biocompatible materials; Bone regeneration; Osteoblasts; Osteogenic growth peptide

Indexed keywords

ALKALINE PHOSPHATASE; HISTONE; OLIGOPEPTIDE; OSTEOGENIC GROWTH PEPTIDE; SIGNAL PEPTIDE;

ANIMAL; BONE; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; HUMAN; INJURIES; METABOLISM; OSTEOBLAST; SYNTHESIS;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE MARROW CELLS; BONE REGENERATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION; HISTONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOGENESIS;

EID: 84996600361     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17111885     Document Type: Review

References (73)

1. Mundy, G.R. Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin. Orthop. Relat. Res. 1996, 324, 24–28.
2. Bartold, P.M.; McCulloch, C.A.; Narayanan, A.S.; Pitaru, S. Tissue engineering: A new paradigm for periodontal regeneration based on molecular and cell biology. Periodontology 2000 2000, 24, 253–269.
3. Terranova, V.P.; Wikesjo, U.M. Extracellular matrices and polypeptide growth factors as mediators of functions of cells of the periodontium. A review. J. Periodontol. 1987, 58, 371–380.
4. Gautschi, O.P.; Frey, S.P.; Zellweger, R. Bone morphogenetic proteins in clinical applications. ANZ J. Surg. 2007, 77, 626–631.
5. Rodan, S.B.; Wesolowski, G.; Yoon, K.; Rodan, G.A. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 1989, 264, 19934–19941.
6. Bosetti, M.; Leigheb, M.; Brooks, R.A.; Boccafoschi, F.; Cannas, M.F. Regulation of osteoblast and osteoclast functions by FGF-6. J. Cell. Physiol. 2010, 225, 466–471.
7. Lin, J.M.; Callon, K.E.; Lin, J.S.; Watson, M.; Empson, V.; Tong, P.C.; Grey, A.; Naot, D.; Green, C.R.; Reid, I.R.; et al. Actions of fibroblast growth factor-8 in bone cells in vitro. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E142–E150.
8. Shimoaka, T.; Ogasawara, T.; Yonamine, A.; Chikazu, D.; Kawano, H.; Nakamura, K.; Itoh, N.; Kawaguchi, H. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J. Biol. Chem. 2002, 277, 7493–7500.
9. Zhao, L.; Jiang, S.; Hantash, B.M. Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue Eng. Part A 2010, 16, 725–733.
10. Zhou, S. TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J. Cell. Biochem. 2011, 112, 1651–1660.
11. Zhang, W.; Shen, X.; Wan, C.; Zhao, Q.; Zhang, L.; Zhou, Q.; Deng, L. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: Differential signalling via Akt and ERK. Cell Biochem. Funct. 2012, 30, 297–302.
12. Ren, Y.; Yu, L.; Fan, J.; Rui, Z.; Hua, Z.; Zhang, Z.; Zhang, N.; Yin, G. Phosphorylation of GIT1 tyrosine 321 is required for association with FAK at focal adhesions and for PDGF-activated migration of osteoblasts. Mol. Cell. Biochem. 2012, 365, 109–118.
13. Kim, I.S.; Song, Y.M.; Cho, T.H.; Park, Y.D.; Lee, K.B.; Noh, I.; Weber, F.; Hwang, S.J. In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation. Dev. Growth Differ. 2008, 50, 553–664.
14. Chang, S.F.; Chang, T.K.; Peng, H.H.; Yeh, Y.T.; Lee, D.Y.; Yeh, C.R.; Zhou, J.; Cheng, C.K.; Chang, C.A.; Chiu, J.J. BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21 CIP1 and p27 KIP1 regulation. Mol. Endocrinol. 2009, 23, 1827–1838.
15. Takahashi, K.; Ogura, N.; Aonuma, H.; Ito, K.; Ishigami, D.; Kamino, Y.; Kondoh, T. Bone morphogenetic protein 6 stimulates mineralization in human dental follicle cells without dexamethasone. Arch. Oral Biol. 2013, 58, 690–698.
16. Lavery, K.; Hawley, S.; Swain, P.; Rooney, R.; Falb, D.; Alaoui-Ismaili, M.H. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone 2009, 45, 27–41.
17. D’Alimonte, I.; Nargi, E.; Mastrangelo, F.; Falco, G.; Lanuti, P.; Marchisio, M.; Miscia, S.; Robuffo, I.; Capogreco, M.; Buccella, S.; et al. Vascular endothelial growth factor enhances in vitro proliferation and osteogenic differentiation of human dental pulp stem cells. J. Biol. Regul. Homeost. Agents 2011, 25, 57–69.
18. Laflamme, C.; Curt, S.; Rouabhia, M. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch. Oral Biol. 2010, 55, 689–701.
19. Kawaki, H.; Kubota, S.; Suzuki, A.; Suzuki, M.; Kohsaka, K.; Hoshi, K.; Fujii, T.; Lazar, N.; Ohgawara, T.; Maeda, T.; et al. Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways. Bone 2011, 49, 975–989.
20. Xin, C.; Bingbing, Z.; Yuanliang, W.; Chengyu, X.; Li, Y.; Moyuan, D.; Qin, P.; Yuxiao, L. Mechano-growth factor E peptide inhibits the differentiation and mineralization of osteoblasts. Arch. Oral Biol. 2012, 57, 720–727.
21. Ikenoue, T.; Jingushi, S.; Urabe, K.; Okazaki, K.; Iwamoto, Y. Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells. J. Cell. Biochem. 1999, 75, 206–214.
22. Komaki, M.; Karakida, T.; Abe, M.; Oida, S.; Mimori, K.; Iwasaki, K.; Noguchi, K.; Oda, S.; Ishikawa, I. Twist negatively regulates osteoblastic differentiation in human periodontal ligament cells. J. Cell. Biochem. 2007, 100, 303–314.
23. Grano, M.; Galimi, F.; Zambonin, G.; Colucci, S.; Cottone, E.; Zallone, A.Z.; Comoglio, P.M. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc. Natl. Acad. Sci. USA 1996, 93, 7644–7648.
24. D’Ippolito, G.; Schiller, P.C.; Perez-stable, C.; Balkan, W.; Roos, B.A.; Howard, G.A. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 2002, 31, 269–275.
25. Koch, F.P.; Weinbach, C.; Hustert, E.; Al-Nawas, B.; Wagner, W. GDF-5 and BMP-2 regulate bone cell differentiation by gene expression of MSX1, MSX2, Dlx5, and Runx2 and influence OCN gene expression in vitro. Int. J. Periodontics Restor. Dent. 2012, 32, 285–293.
26. Kim, S.; Lee, J.C.; Cho, E.S.; Kwon, J. COMP-Ang1 promotes chondrogenic and osteogenic differentiation of multipotent mesenchymal stem cells through the Ang1/Tie2 signaling pathway. J. Orthop Res. 2013, 31, 1920–1928.
27. Abdallah, B.M.; Jensen, C.H.; Gutierrez, G.; Leslie, R.G.; Jensen, T.G.; Kassem, M. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J. Bone Miner. Res. 2004, 19, 841–852.
28. Ono, M.; Inkson, C.A.; Kilts, T.M.; Young, M.F. WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J. Bone Miner. Res. 2011, 26, 193–208.
29. Nakamura, A.; Ly, C.; Cipetic, M.; Sims, N.A.; Vieusseux, J.; Kartsogiannis, V.; Bouralexis, S.; Saleh, H.; Zhou, H.; Price, J.T.; et al. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro. Bone 2007, 40, 305–315.
30. Guise, T.A.; Yin, J.J.; Mohammad, K.S. Role of endothelin-1 in osteoblastic bone metastases. Cancer 2003, 97 (Suppl. 3), 779–784.
31. Hou, J.M.; Wu, M.; Lin, Q.M.; Lin, F.; Xue, Y.; Lan, X.H.; Chen, E.Y.; Wang, M.L.; Yang, H.Y.; Wang, F.X. Lactoferrin promote primary rat osteoblast proliferation and differentiation via up-regulation of insulin-like growth factor-1 expression. Mol. Biol. Rep. 2014, 41, 5019–5030.
32. Online Mendelian Inheritance. Available online: www.omim.org (accessed on 9 November 2015).
33. Bab, I.; Gazit, D.; Chorev, M.; Muhlrad, A.; Shteyer, A.; Greenberg, Z.; Namdar, M.; Kahn, A. Histone H4-related osteogenic growth peptide (OGP): A novel circulating stimulator of osteoblastic activity. EMBO J 1992, 11, 1867–1873.
34. Gabarin, N.; Gavish, H.; Muhlrad, A.; Chen, Y.C.; Namdar-Attar, M.; Nissenson, R.A.; Chorev, M.; Bab, I. Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: Activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10–14)] and attenuation of activation by cAMP. J. Cell. Biochem. 2001, 81, 594–603.
35. Greenberg, Z.; Chorev, M.; Muhlrad, A.; Shteyer, A.; Namdar, M.; Mansur, N.; Bab, I. Mitogenic action of osteogenic growth peptide (OGP): Role of amino and carboxy-terminal regions and charge. Biochim. Biophys. Acta 1993, 1178, 273–280.
36. Chen, Y.C.; Muhlrad, A.; Shteyer, A.; Vidson, M.; Bab, I.; Chorev, M. Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10–14). J. Med. Chem. 2002, 45, 1624–1632.
37. Chen, Z.X.; Chang, M.; Peng, Y.L.; Zhao, L.; Zhan, Y.R.; Wang, L.J.; Wang, R. Osteogenic growth peptide C-terminal pentapeptide [OGP(10–14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes. Regul. Pept. 2007, 142, 16–23.
38. Brager, M.A.; Patterson, M.J.; Connolly, J.F.; Nevo, Z. Osteogenic growth peptide normally stimulated by blood loss and marrow ablation has local and systemic effects on fracture healing in rats. J. Orthop. Res. 2000, 18, 133–139.
39. Sun, Y.Q.; Ashhurst, D.E. Osteogenic growth peptide enhances the rate of fracture healing in rabbits. Cell Biol. Int. 1998, 22, 313–319.
40. Chen, Y.C.; Bab, I.; Mansur, N.; Muhlrad, A.; Shteyer, A.; Namdar-Attar, M.; Gavish, H.; Vidson, M.; Chorev, M. Structure-bioactivity of C-terminal pentapeptide of osteogenic growth peptide [OGP(10–14)]. J. Pept. Res. 2000, 56, 147–156.
41. Bab, I.; Smith, E.; Gavish, H.; Attar-Namdar, M.; Chorev, M.; Chen, Y.C.; Muhlrad, A.; Birnbaum, M.J.; Stein, G.; Frenkel, B. Biosynthesis of osteogenic growth peptide via alternative translational initiation at AUG85 of histone H4 mRNA. J. Biol. Chem. 1999, 274, 14474–14481.
42. Kozak, M. An analysis of vertebrate mRNA sequences: Intimations of translational control. J. Cell Biol. 1991, 115, 887–903.
43. Greenberg, Z.; Chorev, M.; Muhlrad, A.; Shteyer, A.; Namdar-Attar, M.; Casap, N.; Tartakovsky, A.; Vidson, M.; Bab, I. Structural and functional characterization of osteogenic growth peptide from human serum: identity with rat and mouse homologs. J. Clin. Endocrinol. Metab. 1995, 80, 2330–2335.
44. Gavish, H.; Bab, I.; Tartakovsky, A.; Chorev, M.; Mansur, N.; Greenberg, Z.; Namdar-Attar, M.; Muhlrad, A. Human alpha 2-macroglobulin is an osteogenic growth peptide-binding protein. Biochemistry 1997, 36, 14883–14888.
45. Policastro, G.M.; Lin, F.; Smith Callahan, L.A.; Esterle, A.; Graham, M.; Sloan Stakleff, K.; Becker, M.L. OGP functionalized phenylalanine-based poly(ester urea) for enhancing osteoinductive potential of human mesenchymal stem cells. Biomacromolecules 2015, 16, 1358–1371.
46. Chu, C.T.; Pizzo, S.V. alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab. Investig. 1994, 71, 792–812.
47. Greenberg, Z.; Gavish, H.; Muhlrad, A.; Chorev, M.; Shteyer, A.; Attar-Namdar, M.; Tartakovsky, A.; Bab, I. Isolation of osteogenic growth peptide from osteoblastic MC3T3 E1 cell cultures and demonstration of osteogenic growth peptide binding proteins. J. Cell. Biochem. 1997, 65, 359–367.
48. Bab, I.; Gavish, H.; Namdar-Attar, M.; Muhlrad, A.; Greenberg, Z.; Chen, Y.; Mansur, N.; Shteyer, A.; Chorev, M. Isolation of mitogenically active C-terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cells. J. Pept. Res. 1999, 54, 408–414.
49. Bab, I.; Chorev, M. Osteogenic growth peptide: from concept to drug design. Biopolymers 2002, 66, 33–48.
50. Kerr, M.A.; Kenny, A.J. The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border. Biochem. J. 1974, 137, 489–495.
51. Roques, B.P.; Noble, F.; Dauge, V.; Fournie-Zaluski, M.C.; Beaumont, A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 1993, 45, 87–146.
52. Spreafico, A.; Frediani, B.; Capperucci, C.; Leonini, A.; Gambera, D.; Ferrata, P.; Rosini, S.; di Stefano, A.; Galeazzi, M.; Marcolongo, R. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis. J. Cell. Biochem. 2006, 98, 1007–1020.
53. Robinson, D.; Bab, I.; Nevo, Z. Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J. Bone Miner. Res. 1995, 10, 690–696.
54. An, G.; Xue, Z.; Zhang, B.; Deng, Q.K.; Wang, Y.S.; Lv, S.C. Expressing osteogenic growth peptide in the rabbit bone mesenchymal stem cells increased alkaline phosphatase activity and enhanced the collagen accumulation. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 1618–1624.
55. Fei, Q.; Guo, C.; Xu, X.; Gao, J.; Zhang, J.; Chen, T.; Cui, D. Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2/cyclin A. Acta Biochim. Biophys. Sin. 2010, 42, 801–806.
56. Vanella, L.; Kim, D.H.; Asprinio, D.; Peterson, S.J.; Barbagallo, I.; Vanella, A.; Goldstein, D.; Ikehara, S.; Kappas, A.; Abraham, N.G. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 2010, 46, 236–243.
57. Chen, Z.; Wang, X.; Shao, Y.; Shi, D.; Chen, T.; Cui, D.; Jiang, X. Synthetic osteogenic growth peptide promotes differentiation of human bone marrow mesenchymal stem cells to osteoblasts via RhoA/ROCK pathway. Mol. Cell. Biochem. 2011, 358, 221–227.
58. Miguel, S.M.; Namdar-Attar, M.; Noh, T.; Frenkel, B.; Bab, I. ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J. Biol. Chem. 2005, 280, 37495–37502.
59. Chen, C.; Qiu, Z.Y.; Zhang, S.M.; Lee, I.S. Biomimetic fibronectin/mineral and osteogenic growth peptide/mineral composites synthesized on calcium phosphate thin films. Chem. Commun. (Camb.) 2011, 47, 11056–11058.
60. Li, H.; Zhang, Z.; Chen, Z.; Zhang, D. Osteogenic growth peptide promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL13. Biochem. Biophys. Res. Commun. 2015, 466, 82–88.
61. Lisignoli, G.; Piacentini, A.; Toneguzzi, S.; Grassi, F.; Tschon, M.; Cristino, S.; Facchini, A.; Mariani, E. Age-associated changes in functional response to CXCR3 and CXCR5 chemokine receptors in human osteoblasts. Biogerontology 2003, 4, 309–317.
62. Tonnarelli, B.; Manferdini, C.; Piacentini, A.; Codeluppi, K.; Zini, N.; Ghisu, S.; Facchini, A.; Lisignoli, G. Surface-dependent modulation of proliferation, bone matrix molecules, and inflammatory factors in human osteoblasts. J. Biomed. Mater. Res. Part A 2009, 89, 687–696.
63. Gabet, Y.; Muller, R.; Regev, E.; Sela, J.; Shteyer, A.; Salisbury, K.; Chorev, M.; Bab, I. Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone 2004, 35, 65–73.
64. Zhao, Z.Y.; Shao, L.; Zhao, H.M.; Zhong, Z.H.; Liu, J.Y.; Hao, C.G. Osteogenic growth peptide accelerates bone healing during distraction osteogenesis in rabbit tibia. J. Int. Med. Res. 2011, 39, 456–463.
65. Lavini, F.; Dall’Oca, C.; Bartolozzi, P. Bone transport and compression-distraction in the treatment of bone loss of the lower limbs. Injury 2010, 41, 1191–1195.
66. Shuqiang, M.; Kunzheng, W.; Xiaoqiang, D.; Wei, W.; Mingyu, Z.; Daocheng, W. Osteogenic growth peptide incorporated into PLGA scaffolds accelerates healing of segmental long bone defects in rabbits. J. Plast. Reconstr. Aesthet. Surg. 2008, 61, 1558–1560.
67. Gottlow, J.; Nyman, S.; Karring, T.; Lindhe, J. New attachment formation as the result of controlled tissue regeneration. J. Clin. Periodontol. 1984, 11, 494–503.
68. Saska, S.; Scarel-Caminaga, R.M.; Teixeira, L.N.; Franchi, L.P.; Dos Santos, R.A.; Gaspar, A.M.; de Oliveira, P.T.; Rosa, A.L.; Takahashi, C.S.; Messaddeq, Y.; et al. Characterization and in vitro evaluation of bacterial cellulose membranes functionalized with osteogenic growth peptide for bone tissue engineering. J. Mater. Sci. Mater. Med. 2012, 23, 2253–2266.
69. Pigossi, S.C.; de Oliveira, G.J.; Finoti, L.S.; Nepomuceno, R.; Spolidorio, L.C.; Rossa, C., Jr.; Ribeiro, S.J.; Saska, S.; Scarel-Caminaga, R.M. Bacterial cellulose-hydroxyapatite composites with osteogenic growth peptide (OGP) or pentapeptide OGP on bone regeneration in critical-size calvarial defect model. J. Biomed. Mater. Res. A 2015, 103, 3397–3406.
70. Mendes, L.S.; Saska, S.; Martines, M.A.; Marchetto, R. Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as osteogenic growth peptide carriers. Mater. Sci. Eng. C Mater. Biol. Appl. 2013, 33, 4427–4434.
71. Maia, F.R.; Barbosa, M.; Gomes, D.B.; Vale, N.; Gomes, P.; Granja, P.L.; Barrias, C.C. Hydrogel depots for local co-delivery of osteoinductive peptides and mesenchymal stem cells. J. Control. Release 2014, 189, 158–168.
72. Stakleff, K.S.; Lin, F.; Smith Callahan, L.A.; Wade, M.B.; Esterle, A.; Miller, J.; Graham, M.; Becker, M.L. Resorbable, amino acid-based poly(ester urea)s crosslinked with osteogenic growth peptide with enhanced mechanical properties and bioactivity. Acta Biomater. 2013, 9, 5132–5142.
73. Parisi-Amon, A.; Mulyasasmita, W.; Chung, C.; Heilshorn, S.C. Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells. Adv. Healthc. Mater. 2013, 2, 428–432.